Khiron Life Sciences has entered into a sales and distribution agreement with Locatel, a pharmacy, healthcare products, and medical equipment retailer with a database of over 2 million patients in Colombia. The agreement immediately brings Khiron's medical cannabis products to Locatel's pharmacies and medical equipment stores in Bogota and Cartagena.
"Khiron is the only company to have all necessary permits and certificates to sell medical cannabis in Colombia, and now the focus is on service and solving patient needs for the last mile," comments Alvaro Torres, Khiron CEO and director. "The Locatel brand is highly respected among Colombians and the company's philosophy aligns with our own. We look forward to partnering with Locatel to improve access to medical cannabis for patients throughout the country."
Effective immediately Khiron's low-THC, CBD-rich magistral preparations will be available through Locatel stores across Colombia's largest urban centres, including in Bogota, with a population of 10 million, and Cartagena, with a population of 1 million.
"This has always been about providing people with medicine they vitally need, and it must be available with home delivery, and for pick up at trusted locations such as Locatel," Torres continued.
"With our large customer network, customer database, and commitment to patient health, working with Khiron is a clear strategic opportunity for both organizations. Like us, Khiron is focused on patient care and we commend them for achieving this milestone to bring medical cannabis to Colombia," comments Eurice Troya, CEO Locatel Colombia.
For more information:
Khiron Life Sciences Corp.
khiron.ca